Cited by 210Alzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration MechanismsDementia and Cognitive Impairment Research

Trem2 Deletion Reduces Late-Stage Amyloid Plaque Accumulation, Elevates the Aβ42:Aβ40 Ratio, and Exacerbates Axonal Dystrophy and Dendritic Spine Loss in the PS2APP Alzheimer's Mouse Model

Open access
Meilandt, William J., Ngu, Hai, Gogineni, Alvin, Lalehzadeh, Guita, Lee, Seung-Hye, Srinivasan, Karpagam, Imperio, Jose, Wu, Tiffany +12 more·2020·The Journal of Neuroscience

Abstract

TREM2 is an Alzheimer's disease (AD) risk gene expressed in microglia. To study the role of Trem2 in a mouse model of β-amyloidosis, we compared PS2APP transgenic mice versus PS2APP mice lacking Trem2 (PS2APP;Trem2 ko ) at ages ranging from 4 to 22 months. Microgliosis was impaired in PS2APP;Trem2 ko mice, with Trem2 -deficient microglia showing compromised expression of proliferation/Wnt-related genes and marked accumulation of ApoE. Plaque abundance was elevated in PS2APP;Trem2 ko females at 6–7 months; but by 12 or 19–22 months of age, it was notably diminished in female and male PS2APP;Trem2 ko mice, respectively. Across all ages, plaque morphology was more diffuse in PS2APP;Trem2 ko brains, and the Aβ42:Aβ40 ratio was elevated. The amount of soluble, fibrillar Aβ oligomers also increased in PS2APP;Trem2 ko hippocampi. Associated with these changes, axonal dystrophy was exacerbated from 6 to 7 months onward in PS2APP;Trem2 ko mice, notwithstanding the reduced plaque load at later ages. PS2APP;Trem2 ko mice also exhibited more dendritic spine loss around plaque and more neurofilament light chain in CSF. Thus, aggravated neuritic dystrophy is a more consistent outcome of Trem2 deficiency than amyloid plaque load, suggesting that the microglial packing of Aβ into dense plaque is an important neuroprotective activity. SIGNIFICANCE STATEMENT Genetic studies indicate that TREM2 gene mutations confer increased Alzheimer's disease (AD) risk. We studied the effects of Trem2 deletion in the PS2APP mouse AD model, in which overproduction of Aβ peptide leads to amyloid plaque formation and associated neuritic dystrophy. Interestingly, neuritic dystrophies were intensified in the brains of Trem2 -deficient mice, despite these mice displaying reduced plaque accumulation at later ages (12–22 months). Microglial clustering around plaques was impaired, plaques were more diffuse, and the Aβ42:Aβ40 ratio and amount of soluble, fibrillar Aβ oligomers were elevated in Trem2 -deficient brains. These results suggest that the Trem2-dependent compaction of Aβ into dense plaques is a protective microglial activity, limiting the exposure of neurons to toxic Aβ species.

AI snapshot

Written from the paper’s full text.

TL;DR

In PS2APP mice, Trem2 deletion impairs plaque-associated microgliosis and shifts amyloid pathology toward a more diffuse, Aβ42-enriched form, with reduced late-stage plaque load but worse axonal dystrophy and spine loss. The authors conclude that Trem2-dependent microglial activation is mainly neuroprotective in β-amyloidosis and that neuronal pathology is a better readout than plaque load.

Key findings

  • Trem2 deletion impaired microglial responses to plaque: reduced Iba1+ clusters, CD68 staining, CD45high microglia, and methoxy-X04+ amyloid-containing microglia across ages; RNAseq found 144 transcripts reduced and only 7 increased in PS2APP;Trem2ko microglia (≥2-fold, adjusted p ≤ 0.05), including impaired proliferation/Wnt-related genes.
  • Plaque effects were age- and sex-dependent: plaque load was increased in 6–7 month PS2APP;Trem2ko females, but reduced in 12 month females and 19–22 month males; plaques were more diffuse in Trem2ko brains at all ages tested, and amber cores were reduced in Trem2het and nearly absent in Trem2ko aged males.
  • Aβ42:Aβ40 ratio was elevated in PS2APP;Trem2ko brains in both TBS and GuHCl fractions across ages, with increased soluble fibrillar oligomers by OC dot blot; ApoE accumulated in Trem2ko microglia in 12 month females despite no difference in microglial Apoe mRNA.
  • Neuronal pathology worsened: plaque-associated Lamp1+ axonal dystrophy and total Lamp1+ area increased from 7 months onward in Trem2ko mice; amino cupric silver degeneration was greater at 12 months in females and 19–22 months in males; CSF NfL was significantly higher in Trem2ko mice, while plasma NfL did not differ; plaque-proximal dendritic spine density was lower in Trem2ko than Trem2wt or Trem2het mice, with spine density ~50% reduced near plaque versus distal segments.

Methods

  • Compared PS2APP transgenic mice with PS2APP;Trem2ko mice across ages 4 to 22 months, using single-sex cohorts: females at 4, 6–7, and 12 months; males at 6–7 and 19–22 months, plus a 19–22 month male cohort including Trem2het mice.
  • Used histology and whole-slide imaging for plaque, Iba1, CD68, Gfap, Lamp1, ApoE, and silver stains; flow cytometry/FACS for brain-resident myeloid cells; RNAseq of sorted microglia; Aβ40/Aβ42 ELISA; nondenaturing dot blots; two-photon imaging of plaque and dendritic spines; and Simoa NfL measurements in CSF/plasma.
  • Main analyses included unpaired t tests, one-way ANOVA with Tukey’s multiple-comparisons, differential expression with voom+limma, GO overrepresentation, and gene set scoring.

Limitations

  • Stated in the paper: RNAseq was from bulk sorted brain myeloid cells, not single-cell resolution; the CSF/plasma NfL cohort was not littermates and was assembled specifically for NfL measurements after a peer-review recommendation; aged male numbers were depleted, so available Trem2het mice were included to round out that analysis.
  • Evident from the text: findings are from a mouse β-amyloidosis model and may not translate directly to human AD; several cohorts were processed as separate batches, and some flow cytometry/methoxy-X04 analyses used very small n (e.g., n = 3 Trem2wt and n = 2 Trem2ko).
  • Evident from the text: the study reports histopathological and biochemical outcomes, not cognitive/behavioral measures, so the functional consequences of the observed neuronal pathology are not directly tested.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1523/jneurosci.1871-19.2019

Cites

98 of 98 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Claims the paper makes

0 of 74 cited sources checked · 0 supported · 0 flagged

  • Findingown data

    PS2APP;Trem2ko mice at 12 months of age have elevated neurofilament-L in the CSF.

    “elevated neurofilament-L in the CSF”
    Quote in the paperSubstantial claim
  • Findingcitation

    The dependence of these transcripts on Trem2 for their induction in PS2APP microglia was approximately concordant with published data from sorted microglial populations from the 5xFAD model.

    “The dependence of these transcripts on Trem2 for their induction in PS2APP microglia was approximately concordant with published data from sorted microglial populations from the 5xFAD model (Wang et al., 2015) (Fig. 2A).”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Wang et al., 2015

      Not checked in the free run.

  • Findingown data

    PS2APP;Trem2ko mice at 12 months of age have increased levels of soluble fibrillar oligomeric Aβ.

    “increased levels of soluble fibrillar oligomeric Aβ”
    Quote in the paperSubstantial claim
  • Findingown data

    In 12 month PS2APP;Trem2ko animals, the fraction of Iba1 and methoxy-X04 signals that colocalized with each other is significantly reduced.

    “Analysis of confocal z-stack images of cortical tissue from 12 month PS2APP;Trem2ko animals also found a significant reduction in the fraction of Iba1 and methoxy-X04 signals that colocalized with each other (Fig. 1-1).”
    Quote in the paperSubstantial claim
  • Findingcitation

    Applying cutoffs of ≥2-fold change and adjusted p value ≤ 0.05, only 7 transcripts had increased abundance in PS2APP;Trem2ko versus PS2APP;Trem2wt microglia (excluding Treml1, an artifact of the KO cassette insertion).

    “Applying cutoffs of ≥2-fold change and adjusted p value ≤ 0.05, we observed only 7 transcripts with increased abundance in PS2APP;Trem2ko versus PS2APP;Trem2wt microglia (excluding Treml1, an artifact of the KO cassette insertion) (Kang et al., 2018).”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites Kang et al., 2018

      Not checked in the free run.

  • May combine two claims. 42
  • The quote only partly states this claim. 1
  • Classified as probably not a substantial claim. 29
  • May combine two claims. The quote only partly states this claim.

    Findingown data

    PS2APP;Trem2ko mice at 12 months of age have ApoE-laden microglia, with marked accumulation of ApoE in Trem2-deficient microglia.

    “Trem2-deficient microglia showing compromised expression of proliferation/Wnt-related genes and marked accumulation of ApoE.”
    • Also stated in: § Introduction · plain
      “Additional analyses of PS2APP;Trem2ko mice at 12 months of age revealed ApoE-laden microglia”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    Other GO biological processes downregulated in PS2APP;Trem2ko microglia included positive regulation of bone resorption (fold enrichment = 24.6, FDR = 0.030), protein kinase B signaling (16.2, 0.047), negative regulation of tumor necrosis factor production (14.1, 0.026), positive regulation of smooth muscle cell migration (13.9, 0.025), transmembrane receptor protein tyrosine kinase signaling (5.9

    “Other GO biological processes implicated as being downregulated in PS2APP;Trem2ko microglia included positive regulation of bone resorption (fold enrichment = 24.6, FDR = 0.030), protein kinase B signaling (fold enrichment = 16.2, FDR = 0.047), negative regulation of tumor necrosis factor production (fold enrichment = 14.1, FDR = 0.026), positive regulation of smooth muscle cell migration (fold”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    In PS2APP compared with nontransgenic microglia, the Neurodegeneration-related, Interferon-related, Proliferation, and LPS-related modules were upregulated, whereas the Microglia and Brain Myeloid modules were modestly but significantly downregulated.

    “In PS2APP compared with nontransgenic microglia, several of these gene sets were upregulated, including the Neurodegeneration-related, Interferon-related, Proliferation, and LPS-related modules, whereas the Microglia and Brain Myeloid modules that typify microglia in their “homeostatic” or “resting” state were modestly but significantly downregulated (Fig. 2D; Fig. 2-3.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    Even though only 5 of 82 genes in the Proliferation module were upregulated strongly enough in PS2APP microglia to reach genome-wide significance (adjusted p ≤ 0.05), the overall expression of the module was clearly enriched compared with microglia from nontransgenic mice.

    “For instance, even though only 5 of 82 genes in the Proliferation module were upregulated strongly enough in PS2APP microglia to reach genome-wide significance (adjusted p ≤ 0.05), the overall expression of the module was clearly enriched compared with microglia from nontransgenic mice (Fig. 2D; Fig. 2-3.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    Despite only 2 of 82 genes (Ccna2 and Aspm) showing significant reduction in transcript abundance after correction for genome-wide analysis, the overall induction of the Proliferation module was compromised in PS2APP;Trem2ko microglia.

    “Again, despite only 2 of 82 genes (Ccna2 and Aspm) showing significant reduction in transcript abundance after correction for genome-wide analysis, the overall induction of the Proliferation module was compromised in PS2APP;Trem2ko microglia (Fig. 2D; Fig. 2-3).”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    Consistent changes in plaque compaction and composition were observed across ages and sexes in PS2APP;Trem2ko brains, in contrast to total plaque burden which varied with age or sex.

    “In contrast to the effects of Trem2 deletion on total plaque burden that varied with age or sex, we observed consistent changes in plaque compaction and composition across ages and sexes.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    Plaque load was reduced in 12 month PS2APP;Trem2ko females and in 19-22 month PS2APP;Trem2ko males compared with PS2APP;Trem2wt mice.

    “We expected to see further exacerbation of amyloid plaque load in Trem2-deficient brains at more advanced ages, but, to our surprise, plaque load was reduced in 12 month PS2APP;Trem2ko females and in 19–22 month PS2APP;Trem2ko males compared with PS2APP;Trem2wt mice (Fig. 3A,B).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    When using the pan-reactive 6E10 Aβ antibody to detect total Aβ species in the soluble fraction, abundance trended slightly downward in PS2APP;Trem2ko mice and correlated negatively with Aβ42:Aβ40 ratio.

    “In contrast, when we used the pan-reactive 6E10 Aβ antibody to detect total Aβ species in this fraction, the abundance trended slightly downward in PS2APP;Trem2ko mice and correlated negatively with Aβ42:Aβ40 ratio (Fig. 5F–H).”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    Using Campbell-Switzer silver stain, plaque burden was increased in 6-7 month PS2APP;Trem2ko females, and trending upward but not reaching significance in 6-7 month PS2APP;Trem2ko males.

    “Indeed, using the Campbell-Switzer silver stain to label amyloid plaque (Campbell et al., 1987; Switzer, 2000), we observed that plaque burden was increased in 6–7 month PS2APP;Trem2ko females, and trending upward but not reaching significance in 6–7 month PS2APP;Trem2ko males (Fig. 3A,B).”
    Quote in the paperNot a substantial claim0 of 2 sources checked
    • cites Campbell et al., 1987

      Not checked in the free run.

    • cites Switzer, 2000

      Not checked in the free run.

  • May combine two claims.

    Findingown data

    The downregulation of the Microglia and Brain Myeloid modules that normally occurs during CNS challenge was not prevented by Trem2 deletion; expression of these modules was similar in PS2APP;Trem2wt and PS2APP;Trem2ko microglia.

    “Unlike the clear requirement of Trem2 for induction of many genes in the Neurodegeneration-related gene set, the downregulation of the Microglia and Brain Myeloid modules that normally occurs during any CNS challenge (Friedman et al., 2018) was not prevented by Trem2 deletion since expression of these modules was similar in PS2APP;Trem2wt and PS2APP;Trem2ko microglia (Fig. 2D; Fig. 2-3).”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Friedman et al., 2018

      Not checked in the free run.

  • May combine two claims.

    Findingown data

    The elevated Aβ42:Aβ40 ratio in PS2APP;Trem2ko brains resulted more from reduced abundance of Aβ40 than from increased abundance of Aβ42, although Aβ42 abundance was elevated in the 6-7 month females, coinciding with the increased plaque deposition in that group.

    “The elevated Aβ42:Aβ40 ratio in PS2APP;Trem2ko brains resulted more from reduced abundance of Aβ40 than from increased abundance of Aβ42 (Fig. 5-1), although Aβ42 abundance was elevated in the 6–7 month females, coinciding with the increased plaque deposition we observed in that group (Fig. 3A).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    Quantification of plaque-associated ApoE in whole-brain sections found a significant increase in female PS2APP;Trem2ko mice at 6-7 and 12 months of age, but no significant changes in male cohorts at any age tested.

    “In contrast to the findings of Parhizkar et al. (2019), quantification of plaque-associated ApoE in whole-brain sections found a significant increase in female PS2APP;Trem2ko mice at 6–7 and 12 months of age, but no significant changes in male cohorts at any age tested (Fig. 6A).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    Using the conformation-specific OC antibody, significantly higher levels of soluble fibrillar Aβ oligomers were detected in the soluble fraction from PS2APP;Trem2ko mice, and a positive correlation was observed between OC+ fibrillar oligomers and the Aβ42:Aβ40 ratio.

    “Using the conformation-specific OC antibody (Tomic et al., 2009), we detected significantly higher levels of soluble fibrillar Aβ oligomers in the soluble fraction from PS2APP;Trem2ko mice (Fig. 5C,D), and we observed a positive correlation between the amount of OC+ fibrillar oligomers in this fraction and the Aβ42:Aβ40 ratio (Fig. 5E).”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites Tomic et al., 2009

      Not checked in the free run.

  • May combine two claims.

    Findingown data

    Of the 134 genes in the Neurodegeneration-related set, 80 showed upregulation in PS2APP versus normal microglia, and approximately half of these showed impaired induction in PS2APP;Trem2ko microglia (adjusted p ≤ 0.05).

    “Of the 134 genes in this set, 80 showed upregulation in PS2APP versus normal microglia (Friedman et al., 2018), and approximately half of these showed impaired induction in PS2APP;Trem2ko microglia (adjusted p values ≤ 0.05) (Fig. 2E).”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites Friedman et al., 2018

      Not checked in the free run.

  • May combine two claims.

    Findingcitation

    In a recent dataset of bulk microglia RNA-Seq profiles from 5xFAD mice, a twofold decrease in the extent of Apoe induction was seen in Trem2-deficient microglia, but the gene was still highly induced relative to nontransgenic microglia.

    “In a very recent dataset of bulk microglia RNA-Seq profiles from 5xFAD mice (Griciuc et al., 2019), we did see a twofold decrease in the extent of Apoe induction in Trem2-deficient microglia, but the gene was still highly induced relative to the expression level in microglia from nontransgenic mice (Fig. 6F).”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Griciuc et al., 2019

      Not checked in the free run.

  • May combine two claims.

    Findingown data

    The abundance of Aβ peptides rose markedly with age while the Aβ42:Aβ40 ratio declined, particularly in the GuHCl fraction.

    “The abundance of Aβ peptides rose markedly with age while the Aβ42:Aβ40 ratio declined, particularly in the GuHCl fraction (Fig. 5).”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    Amino-cupric-silver staining showed "bouquets" of argyrophilic structures presumably surrounding plaques throughout the cortex and hippocampus, and staining in white matter tracts such as corpus callosum, perforant path, and fornix.

    “Overall, the staining pattern appeared very similar to the Lamp1 stain, with “bouquets” of argyrophilic structures presumably surrounding plaques throughout the cortex and hippocampus. Staining was also observed in relevant white matter tracts, such as the corpus callosum, perforant path, and fornix, suggesting that degenerating axonal processes are not restricted to dystrophic neurites around”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    Amber cores were reduced in PS2APP;Trem2het and nearly absent in PS2APP;Trem2ko brains.

    “These amber cores were reduced in PS2APP;Trem2het and nearly absent in PS2APP;Trem2ko brains, indicating that Trem2-dependent microglial activity is essential for the formation of these particular amyloid structures.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingreasoning

    Plaques in Trem2-deficient mice are more injurious to adjacent neurites but show weaker labeling with molecular probes (Thioflavin S, methoxy-X04 and X-34) related to those used in the clinic (11C-PiB, 18F-Florbetapir).

    “The fact that plaques in Trem2-deficient mice are more injurious to adjacent neurites but show weaker labeling with molecular probes (Thioflavin S, methoxy-X04 and X-34) related to those used in the clinic (11C-PiB, 18F-Florbetapir)”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    Preventing the microglial response to Aβ pathology via Trem2 deletion reversed neither axonal dystrophy nor dendritic spine loss around plaque and indeed made both of these pathologies worse.

    “preventing the microglial response to Aβ pathology via Trem2 deletion reversed neither axonal dystrophy nor dendritic spine loss around plaque and indeed made both of these pathologies worse.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    At all ages examined, and in both sexes, microglial clustering around plaque and other measurements of microglial activation were sharply reduced in PS2APP;Trem2ko mice.

    “At all ages examined, and in both sexes, microglial clustering around plaque and other measurements of microglial activation were sharply reduced in PS2APP;Trem2ko mice.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingreasoning

    From 6-7 months onward, axonal injury was magnified in PS2APP;Trem2ko mice, even at later ages when the abundance of argyrophilic amyloid plaques was diminished.

    “From 6–7 months onward, axonal injury was magnified in PS2APP;Trem2ko mice, even at later ages when the abundance of argyrophilic amyloid plaques was diminished.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    Trem2 deletion has age- and sex-dependent effects on plaque abundance assessed using the Campbell-Switzer silver stain in PS2APP mice, with slightly more plaque in PS2APP;Trem2ko females at 6-7 months of age but markedly less plaque in both female and male PS2APP;Trem2ko mice at later ages.

    “We observed both age- and sex-dependent effects of Trem2 deletion on plaque abundance assessed using the Campbell-Switzer silver stain, with slightly more plaque in PS2APP;Trem2ko females at 6–7 months of age but markedly less plaque in both female and male PS2APP;Trem2ko mice at later ages.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    In 6-month-old female PS2APP mice, plaque-proximal dendritic spine density was not rescued by Trem2 deletion but was further reduced in PS2APP;Trem2ko mice compared with PS2APP;Trem2wt or PS2APP;Trem2het mice.

    “Spine density loss in the proximity of plaques was not rescued by Trem2 deletion, but was actually further exacerbated in PS2APP;Trem2ko mice compared with PS2APP;Trem2wt or PS2APP;Trem2het groups (Fig. 9).”
    • Also stated in: § Axonal dystrophy, dendritic spine loss, and CSF NfL detection are exacerbated in PS2APP;Trem2ko mice · plain
      “Spine density near plaque was lower in PS2APP;Trem2ko mice than in PS2APP;Trem2wt or PS2APP;Trem2het mice.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    Trem2 deletion in amyloidosis models has been reported to either increase or decrease phosphorylation of the endogenous tau protein.

    “Trem2 deletion in amyloidosis models has also been reported to either increase or decrease phosphorylation of the endogenous tau protein (Jay et al., 2015; Wang et al., 2016).”
    Quote in the paperNot a substantial claim0 of 2 sources checked
    • cites Jay et al., 2015

      Not checked in the free run.

    • cites Wang et al., 2016

      Not checked in the free run.

  • Classified as probably not a substantial claim.

    Premisecitation

    Whether Trem2 exerts protective or detrimental functions in mouse models of AD-related neuropathology has been rather unclear.

    “However, whether Trem2 exerts protective or detrimental functions in mouse models of AD-related neuropathology has been rather unclear (Gratuze et al., 2018; Hansen et al., 2018; Ulland and Colonna, 2018).”
    Quote in the paperSubstantial claim0 of 3 sources checked
    • cites Gratuze et al., 2018

      Not checked in the free run.

    • cites Hansen et al., 2018

      Not checked in the free run.

    • cites Ulland and Colonna, 2018

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    In transgenic models of cerebral β-amyloidosis, plaque load has been reported to be increased, decreased, or unchanged in mice that lack Trem2, depending on the model, age, and brain region analyzed.

    “In transgenic models of cerebral β-amyloidosis, plaque load has been reportedly increased, decreased, or unchanged in mice that lack Trem2, depending on the model, age, and brain region being analyzed (Jay et al., 2015, 2017a; Wang et al., 2015, 2016; Yuan et al., 2016; Parhizkar et al., 2019).”
    Quote in the paperNot a substantial claim0 of 3 sources checked
    • cites Jay et al., 2015, 2017a

      Not checked in the free run.

    • cites Wang et al., 2015, 2016

      Not checked in the free run.

    • cites Yuan et al., 2016

      Not checked in the free run.

  • May combine two claims.

    Premisecitation

    TREM2 is an Alzheimer's disease risk gene expressed in microglia.

    “TREM2 is an Alzheimer's disease (AD) risk gene expressed in microglia.”
    Quote in the paperSubstantial claim0 of 2 sources checked
    • cites Guerreiro et al., 2013

      Not checked in the free run.

    • cites Jonsson et al., 2013

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    Asb11 is important for maintaining progenitor cell activity in multiple cell types.

    “Dkk2, Wif1, and Ctnna3 can all negatively regulate Wnt activity (Hsieh et al., 1999; Busby et al., 2004; Gage et al., 2008), whereas Asb11 is important for maintaining progenitor cell activity in multiple cell types (Diks et al., 2006; Tee et al., 2012).”
    Quote in the paperNot a substantial claim0 of 2 sources checked
    • cites Diks et al., 2006

      Not checked in the free run.

    • cites Tee et al., 2012

      Not checked in the free run.

  • Classified as probably not a substantial claim.

    Premisecitation

    Gene expression modules defined by Friedman et al. (2018) can be used to characterize the diverse ways that microglia respond to environmental and genetic perturbations.

    “We recently defined a number of gene expression modules that can be used to characterize the diverse ways that microglia respond to environmental and genetic perturbations (Friedman et al., 2018).”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites Friedman et al., 2018

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Study design and conductnone given

    All animal care and handling procedures were reviewed and approved by the Genentech Institutional Animal Care and Use Committee and were conducted in full compliance with regulatory statutes, Institutional Animal Care and Use Committee policies, and National Institutes of Health guidelines.

    “All animal care and handling procedures were reviewed and approved by the Genentech Institutional Animal Care and Use Committee and were conducted in full compliance with regulatory statutes, Institutional Animal Care and Use Committee policies, and National Institutes of Health guidelines.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductnone given

    Whole-slide image analyses were performed in a blinded manner.

    “MATLAB (The MathWorks) running on a high-performance computing cluster was used for all whole-slide image analyses performed in a blinded manner.”
    Quote in the paperNot a substantial claim
  • Classified as probably not a substantial claim.

    Study design and conductnone given

    Images for X-34 stains were collected and processed blind to genotypes.

    “Images were collected and processed blind to genotypes.”
    Quote in the paperSubstantial claim
  • Classified as probably not a substantial claim.

    Study design and conductreasoning

    To avoid the presence of peripheral myeloid cells in the flow analysis and FACS collections, Ccr2+ cells and Ly6g+ cells were excluded.

    “To avoid the presence of peripheral myeloid cells in the flow analysis and FACS collections, Ccr2+ cells (peripheral monocytes/macrophages) and Ly6g+ cells (neutrophils) were excluded.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Premisecitation

    PS2APP mice develop amyloid plaque and attendant gliosis pathologies that increase with age, with female mice accumulating the pathology more rapidly than males.

    “PS2APP mice develop amyloid plaque and attendant gliosis pathologies that increase with age, with female mice accumulating the pathology more rapidly than males (Ozmen et al., 2009).”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Ozmen et al., 2009

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductreasoning

    All steps in tissue dissociation and cell suspension preparation were performed on ice or at 4°C to prevent artifactual microglial activation.

    “All steps were performed on ice or at 4°C to prevent artifactual microglial activation.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Interpretationown data

    The reductions in total Iba1 and Gfap staining indicate reduced extents of microgliosis and astrogliosis, respectively, in PS2APP;Trem2ko mice.

    “indicative of reduced extents of microgliosis and astrogliosis, respectively, in PS2APP;Trem2ko mice”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    Acquisition of the DAM state is Trem2-dependent in mouse models of AD, amyotrophic lateral sclerosis, and demyelinating disease.

    “The acquisition of the DAM state is Trem2-dependent in mouse models of AD, amyotrophic lateral sclerosis, and demyelinating disease (Poliani et al., 2015; Wang et al., 2015; Keren-Shaul et al., 2017; Krasemann et al., 2017).”
    Quote in the paperNot a substantial claim0 of 3 sources checked
    • cites Poliani et al., 2015

      Not checked in the free run.

    • cites Wang et al., 2015

      Not checked in the free run.

    • cites Keren-Shaul et al., 2017

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    In the hTau model, Trem2 deletion increased the amounts of tau phosphorylation and aggregation detected.

    “In the hTau model (Andorfer et al., 2003), Trem2 deletion increased the amounts of tau phosphorylation and aggregation detected (Bemiller et al., 2017).”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Bemiller et al., 2017

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductnone given

    All images, segmentation overlays, and data were reviewed by a pathologist.

    “All images, segmentation overlays, and data were reviewed by a pathologist.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Premisecitation

    Dkk2, Wif1, and Ctnna3 can all negatively regulate Wnt activity.

    “Dkk2, Wif1, and Ctnna3 can all negatively regulate Wnt activity (Hsieh et al., 1999; Busby et al., 2004; Gage et al., 2008), whereas Asb11 is important for maintaining progenitor cell activity in multiple cell types (Diks et al., 2006; Tee et al., 2012).”
    Quote in the paperNot a substantial claim0 of 3 sources checked
    • cites Hsieh et al., 1999

      Not checked in the free run.

    • cites Busby et al., 2004

      Not checked in the free run.

    • cites Gage et al., 2008

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Study design and conductown data

    CD45low and CD45high gates were defined using a nontransgenic animal as a control, and the same gates were transposed onto cells from PS2APP animals sorted on the same day in the same machine to ensure accuracy and consistency.

    “CD45low and CD45high gates were defined using a nontransgenic animal as a control to identify microglia in their normal state (CD45low). The same gates were transposed onto cells from PS2APP animals sorted on the same day in the same machine to ensure accuracy and consistency in determining percentages of CD45low and CD45high populations.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Study design and conductnone given

    Two sections per animal were stained, with all cohorts stained and analyzed simultaneously.

    “Two sections per animal were stained, with all cohorts stained and analyzed simultaneously.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Interpretationown data

    Trem2-dependent microglial proliferation and activation attenuate the toxic effects of Aβ toward neurons, i.e., the DAM state is mainly protective.

    “Collectively, our data indicate that Trem2-dependent microglial proliferation and activation attenuate the toxic effects of Aβ toward neurons (i.e., the DAM state is mainly protective)”
    Quote in the paperSubstantial claim
    • Rests on an assumption: The effects of Trem2 deletion in PS2APP mice are mediated specifically by microglial Trem2 rather than by other Trem2-expressing myeloid cells or non-myeloid cells.
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductnone given

    Imaging and analysis for two-photon microscopy were performed under blinded conditions.

    “Imaging and analysis were performed under blinded conditions.”
    Quote in the paperNot a substantial claim
  • Classified as probably not a substantial claim.

    Premisecitation

    Transcriptional profiling studies have defined a disease/damage-associated microglial activation state that is commonly observed in the brains of neurodegeneration models.

    “Transcriptional profiling studies have defined a disease/damage-associated microglial (DAM) activation state that is commonly observed in the brains of neurodegeneration models (Deczkowska et al., 2018; Friedman et al., 2018).”
    Quote in the paperSubstantial claim0 of 2 sources checked
    • cites Deczkowska et al., 2018

      Not checked in the free run.

    • cites Friedman et al., 2018

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductnone given

    Animal pairs, including one PS2APP;Trem2wt and one PS2APP;Trem2ko animal, were generally processed together from perfusion through sorting.

    “Generally, animal pairs, including one PS2APP;Trem2wt and one PS2APP;Trem2ko animal, were processed together from perfusion through sorting.”
    Quote in the paperNot a substantial claim
  • Classified as probably not a substantial claim. May combine two claims.

    Study design and conductreasoning

    The 6-7 month cohort of male and female mice was purposely analyzed separately to determine the effects of Trem2 deficiency in each sex since female mice have accelerated amyloid pathology compared with males, and to avoid confounding by age-dependent differences in pathology between males and females.

    “The 6–7 month cohort of male and female mice was purposely analyzed separately to determine the effects of Trem2 deficiency in each sex since female mice have accelerated amyloid pathology compared with males, and we did not want an analysis of interactions between sex and Trem2 genotype to be confounded by the age-dependent differences in pathology between males and females.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    In the PS19 model, Trem2 deletion had a protective effect, preventing tau-driven synaptic loss and atrophy in the hippocampus and entorhinal cortex, respectively.

    “In contrast, in the PS19 model (Yoshiyama et al., 2007), Trem2 deletion had a protective effect, preventing tau-driven synaptic loss and atrophy in the hippocampus and entorhinal cortex, respectively (Leyns et al., 2017).”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Leyns et al., 2017

      Not checked in the free run.

  • May combine two claims.

    Study design and conductown data

    As a control, PS2APP;Bace1ko hippocampal TBS homogenate supernatant showed minimal OC antibody detection but substantial 6E10 signal, consistent with the ability of 6E10 to detect both soluble APP and Aβ peptides.

    “As a control, we spotted hippocampal TBS homogenate supernatant from a PS2APP;Bace1ko animal (Meilandt et al., 2019), in which soluble APP is still produced by α-cleavage while β-cleavage and thus Aβ production are prevented, and demonstrated that the OC antibody had minimal detection, whereas 6E10 still had substantial signal (compare # symbols in Fig. 5C,F and dotted lines in Fig. 5D,G from a PS”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Meilandt et al., 2019

      Not checked in the free run.

  • May combine two claims.

    Interpretationcitation

    The elevated Aβ42:Aβ40 ratio in Trem2-deficient brains may increase plaque seeding at younger ages while reducing the incorporation and compaction of Aβ into existing plaques at older ages.

    “Together with our observation that total amyloid plaque is reduced in PS2APP;Trem2ko brains at later ages (Fig. 3A), these results suggest that the elevated Aβ42:Aβ40 ratio in Trem2-deficient brains may increase plaque seeding at younger ages (since Aβ42 is more prone to aggregate and deposit than Aβ40) (Klein, 2002) while reducing the incorporation and compaction of Aβ into existing plaques at”
    Quote in the paperSubstantial claim0 of 2 sources checked
    • cites Klein, 2002

      Not checked in the free run.

    • cites Condello et al., 2015

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Interpretationcitation

    The authors' results are reminiscent of a recent study of APPPS1 mice, which showed that Trem2 deletion produced increased seeding of amyloid plaques at early ages but slower rates of amyloid plaque accumulation at later ages.

    “Overall, our results are reminiscent of a recent study of APPPS1 mice, which showed that Trem2 deletion produced increased seeding of amyloid plaques at early ages but slower rates of amyloid plaque accumulation at later ages (Parhizkar et al., 2019).”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Parhizkar et al., 2019

      Not checked in the free run.

  • May combine two claims.

    Interpretationown data

    Microglial Apoe expression is induced by Aβ-driven neuropathology in a largely Trem2-independent manner, and Trem2-deficient microglia accumulate disproportionately large amounts of ApoE compared with normal PS2APP microglia.

    “Together, our evidence indicates that microglial Apoe expression is induced by Aβ-driven neuropathology in a largely Trem2-independent manner, and that Trem2-deficient microglia accumulate disproportionately large amounts of ApoE compared with the smaller ApoE puncta observed in normal PS2APP microglia (Fig. 6C).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Interpretationreasoning

    Trem2 may both restrict the initial seeding of plaques and promote sequestration and compaction of Aβ into existing plaques.

    “Thus, Trem2 may both restrict the initial seeding of plaques and promote sequestration and compaction of Aβ into existing plaques.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Interpretationreasoning

    The form rather than the amount of plaque correlates with neuronal damage, and sufficient microgliosis occurs in PS2APP;Trem2het mice to enable plaque compaction and neuroprotection.

    “The intermediate effect of Trem2 heterozygosity on microglial clustering around plaque (Figs. 1A, 7B) and Campbell-Switzer plaque staining (Fig. 3A), but not on plaque diffuseness (Fig. 4B), Aβ42:Aβ40 ratio (Fig. 5A), or neuritic dystrophy (Figs. 7C,D, 8A), suggested that the form rather than the amount of plaque correlates with neuronal damage, and that sufficient microgliosis occurs in PS2APP;T”
    Quote in the paperSubstantial claim
  • Classified as probably not a substantial claim.

    Premisecitation

    Aβ42 oligomers are commonly understood to be the more toxic form of Aβ.

    “The elevated Aβ42:Aβ40 ratio and fibrillar Aβ oligomers in PS2APP;Trem2ko brains would seem to be detrimental for neuronal health since Aβ42 oligomers are commonly understood to be the more toxic form of Aβ (Klein, 2002; Haass and Selkoe, 2007).”
    Quote in the paperSubstantial claim0 of 2 sources checked
    • cites Klein, 2002

      Not checked in the free run.

    • cites Haass and Selkoe, 2007

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    Apoe is one of the most highly induced genes in mouse microglia in response to neurodegenerative stimuli.

    “Apoe is one of the most highly induced genes in mouse microglia in response to neurodegenerative stimuli (Deczkowska et al., 2018).”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Deczkowska et al., 2018

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    NfL measured in CSF or plasma has recently emerged as a potential biomarker of neurodegeneration in human patients and in mouse disease models.

    “NfL measured in the CSF or plasma has recently emerged as a potential biomarker of neurodegeneration in human patients and in mouse disease models (Bacioglu et al., 2016; Khalil et al., 2018).”
    Quote in the paperNot a substantial claim0 of 2 sources checked
    • cites Bacioglu et al., 2016

      Not checked in the free run.

    • cites Khalil et al., 2018

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data

    The authors were blinded to Trem2 genotype during plaque morphology assessment.

    “Although we were blinded to Trem2 genotype, there was an obvious difference in plaque appearance between PS2APP;Trem2wt and PS2APP;Trem2ko brains, with X-34+ structures in PS2APP;Trem2ko brains looking more splayed and less compact (Fig. 4A), similar to descriptions of Trem2-dependent plaque alterations in other β-amyloid models (Wang et al., 2016; Yuan et al., 2016).”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Interpretationreasoning

    Alternatively, the increased abundance of fibrillar Aβ oligomers in the TBS-soluble fraction could result from reduced incorporation into highly condensed plaques in brains with Trem2-deficient microglia.

    “Alternatively, the increased abundance of fibrillar Aβ oligomers in the TBS-soluble fraction could result from reduced incorporation into highly condensed plaques in brains with Trem2-deficient microglia.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Premisecitation

    Elevated PET signal for ligands of the neuroinflammation marker TSPO have predicted better cognitive measures and slower AD progression in mice with β-amyloid pathology and human patients, respectively.

    “elevated PET signal for ligands of the “neuroinflammation marker” TSPO have predicted better cognitive measures and slower AD progression in mice with β-amyloid pathology and human patients, respectively (Hamelin et al., 2016; Focke et al., 2019).”
    Quote in the paperSubstantial claim0 of 2 sources checked
    • cites Hamelin et al., 2016

      Not checked in the free run.

    • cites Focke et al., 2019

      Not checked in the free run.

  • Classified as probably not a substantial claim.

    Premisecitation

    Reduced synaptic density, particularly near plaque, is a feature of AD tissues and β-amyloid mouse models.

    “another feature of neuronal pathology observed in AD tissues and β-amyloid mouse models, reduced synaptic density, particularly near plaque (Spires and Hyman, 2004; Tsai et al., 2004; Spires et al., 2005)”
    Quote in the paperSubstantial claim0 of 3 sources checked
    • cites Spires and Hyman, 2004

      Not checked in the free run.

    • cites Tsai et al., 2004

      Not checked in the free run.

    • cites Spires et al., 2005

      Not checked in the free run.

  • May combine two claims.

    Interpretationcitation

    Trem2-dependent microglial activity may both restrain the formation/seeding of plaques at an early stage of pathology, conceivably through uptake and degradation of soluble Aβ species, but also enhance the sequestration of Aβ into existing plaque structures, particularly at later stages of pathology.

    “Together with a recent similar report (Parhizkar et al., 2019), these results suggest that Trem2-dependent microglial activity may both restrain the formation/seeding of plaques at an early stage of pathology, conceivably through uptake and degradation of soluble Aβ species, but also enhance the sequestration of Aβ into existing plaque structures, particularly at later stages of pathology.”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites Parhizkar et al., 2019

      Not checked in the free run.

  • May combine two claims.

    Premisecitation

    β-amyloid pathology accelerates the accumulation of tau pathology or enhances its spreading in humans and mice.

    “Evidence in humans and mice supports the mechanistic model that β-amyloid pathology accelerates the accumulation of tau pathology or enhances its spreading (Pooler et al., 2015; He et al., 2018; Jack et al., 2018; Jacobs et al., 2018)”
    Quote in the paperNot a substantial claim0 of 3 sources checked
    • cites Pooler et al., 2015

      Not checked in the free run.

    • cites He et al., 2018

      Not checked in the free run.

    • cites Jack et al., 2018

      Not checked in the free run.

  • May combine two claims.

    Interpretationreasoning

    The reduction of plaque accumulation activity in PS2APP;Trem2ko brains may underlie the elevated levels of fibrillar oligomeric Aβ detected in the soluble fraction, which may in turn be a source of increased neuronal injury in these animals.

    “The reduction of this plaque accumulation activity in PS2APP;Trem2ko brains may underlie the elevated levels of fibrillar oligomeric Aβ we detected in the soluble fraction, which may in turn be a source of increased neuronal injury in these animals.”
    Quote in the paperSubstantial claim
65 of 65
  • The paper relies on this without support.

    The effects of Trem2 deletion in PS2APP mice are mediated specifically by microglial Trem2 rather than by other Trem2-expressing myeloid cells or non-myeloid cells.

    “TREM2 is an Alzheimer's disease (AD) risk gene expressed in microglia.”
  • The paper relies on this without support.

    The Trem2tm1(KOMP)Vlcg allele completely abolishes Trem2 function in PS2APP;Trem2ko mice.

    “The Trem2tm1(KOMP)Vlcg null allele (C57BL/6N background) was crossed into the PS2APP model (C57BL/6J background).”
  • The paper relies on this without support.

    Amber core amyloid staining represents a mature form of highly condensed plaque.

    “At this age, the Campbell-Switzer stain also revealed a distinctive pattern of “amber core” amyloid staining in PS2APP brains (Fig. 3C), thought to represent a mature form of highly condensed plaque.”
  • The paper relies on this without support.

    Cognitive decline correlates better with tau pathology and synapse loss than with brain amyloid detection.

    “helps explain why cognitive decline correlates better with tau pathology and synapse loss than with brain amyloid detection.”
4 of 4

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • AD progression is better correlated with tau pathology, neuronal degeneration, Aβ spreading, and synapse loss than Aβ detection alone.

    “AD progression is better correlated with tau pathology, neuronal degeneration, Aβ spreading and synapse loss, rather than Aβ detection alone [222]”

    From Microglia and monocytes in inflammatory CNS disease: integrating phenotype and function (2022) · cites this paper as [222]

    The Discussion (page not provided) says cognitive decline correlates better with tau pathology and synapse loss than with brain amyloid detection, and proposes neuronal-degeneration biomarkers as more informative indicators. It discusses the spreading of tau pathology, not Aβ spreading; that part of the claim is unsupported. (LLM, conf=0.87)

    Experimental — accuracy not yet measured
  • The reduced MOAB2+ plaque sizes may be a result of reduced oligomeric Aβ compaction.

    “which may be a result of reduced oligomeric Aβ compaction as described previously in another amyloidogenic mouse model. 62”

    From PLCG2 modulates TREM2 expression and signaling in response to Alzheimer's disease pathology (2025) · cites this paper as [62]

    The Results section (page not available) suggests that Trem2 deficiency may reduce the incorporation and compaction of Aβ into existing plaques in PS2APP mice. The Discussion also links reduced compact-plaque accumulation with elevated soluble fibrillar Aβ oligomers. The paper does not examine MOAB2+ plaque sizes or specifically show that reduced compaction of oligomeric Aβ causes smaller plaques. (LLM, conf=0.83)

    Experimental — accuracy not yet measured
  • The dichotomy of immune effects on amyloid and tau has been demonstrated in multiple models of Trem2 and Tyrobp.

    “More recently, this dichotomy has been elegantly demonstrated in multiple models of Trem2 and Tyrobp [49–51, 55–59].”

    From Deletion of Abi3/Gngt2 influences age-progressive amyloid β and tau pathologies in distinctive ways (2022) · cites this paper as [57]

    The Introduction (page unavailable) describes differing effects of Trem2 deletion on amyloid plaques and tau pathology across several mouse models, supporting the Trem2 portion of the claim. This paper studies a PS2APP Trem2-deletion model; the passages do not establish the claim about Tyrobp models. (LLM, conf=0.84)

    Experimental — accuracy not yet measured
  • In studies of Trem2 deficiency, differences were dependent on early versus later disease stages.

    “A similar interpretation could be developed from the studies of Trem2 deficiency, as differences were dependent on early versus later disease stages.50,51,57,58”
  • Microglia can have differential effects on Alzheimer's disease pathology depending on the disease stage.

    “These studies have led to the notion that microglia can have differential effects on AD pathology depending on the disease stage.”

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. Campbell, 1987, Alzheimer's plaques and tangles: a controlled and enhanced silver staining method, Soc Neuroscience Abstr, 13, 678

Cited by

Sorted by citations

Authors
Meilandt, W. J., Ngu, H., Gogineni, A., Lalehzadeh, G., Lee, S.-H., Srinivasan, K., Imperio, J., Wu, T., Weber, M., Kruse, A. J., Stark, K. L., Chan, P., Kwong, M., Modrusan, Z., Friedman, B. A., Elstrott, J., Foreman, O., Easton, A., Sheng, M., & Hansen, D. V.
Affiliations
Genentech (US)
Corresponding author
  • Meilandt, William J.
  • Hansen, David V.
Venue
The Journal of Neuroscience
Published
2020-01-24
Volume
40
Issue
9
Pages
1956-1974
ISSN
  • 0270-6474 (ISSN-L)
  • 1529-2401
OpenAlex
W3003126983
Cited by
210
References
98
Citations by year
2026: 16 · 2025: 30 · 2024: 44 · 2023: 48 · 2022: 33 · 2021: 25 · 2020: 14
FWCI
18.04
Type
journal article
Language
en
Open access
Locations
  • Journal of Neuroscience (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion, cc-by-nc)
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords
TREM2, Alzheimer's disease, amyloid plaques, amyloid-beta 42/40 ratio, axonal dystrophy, dendritic spine loss, neuritic dystrophy, microglial activation, soluble amyloid-beta oligomers, neurofilament light chain, apolipoprotein E, Wnt signaling, sex differences
MeSH terms
Trefoil Factor-1, Alzheimer Disease, Animals, Axons, Female, Male, Membrane Glycoproteins, Mice, Inbred C57BL, Peptide Fragments, Receptors, Immunologic, Amyloid beta-Peptides, Neurites, Amyloid beta-Protein Precursor, Neurofilament Proteins, Microglia, Mice, Knockout, Dendritic Spines, Mice, Plaque, Amyloid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-10.

Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-10.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review